Products
Early 2013 it was decided that IQ Products was going to focus more on diagnostics and prognostics in the field of Women’s Health. This focus was initially supported by IQ Products proprietary Fetal Cell CountTM kit, a kit to determine fetomaternal hemorrhage (FMH). Research & Development is currently targeted on pregnancy related disorders and in particular the risk assessment of these disorders at the end of the first trimester, around week 12 of gestation. The first kits have been launched under the name Pregnostic®.
